APOE and early-onset autosomal dominant Alzheimer disease: An independent study further identified that the clinical spectrum of early Alzheimer’s disease pathology is explained by different biological pathways, in particular, the endocytosis, clathrin/AP2 adaptor complex, and immune response pathways, that are independent of apolipoprotein E (APOE) [360].